Un-adjusted model | Adjusted model | |||||
---|---|---|---|---|---|---|
Variable | OR | 95% CI | P-value | OR | 95% CI | P-value |
Gender | ||||||
Female | 1 | 1 | ||||
Male | 1.59 | 0.62–4.06 | 0.330 | 2.03 | 0.67–6.16 | 0.210 |
Age | ||||||
16–24 | 1 | |||||
25–35 | 1.34 | 0.50–3.58 | 0.558 | 1.35 | 0.46–3.93 | 0.58 |
36–50 | 1.77 | 0.59–5.24 | 0.303 | 1.53 | 0.43–5.50 | 0.51 |
51+ | 1.13 | 0.23–5.62 | 0.874 | 0.79 | 0.12–5.30 | 0.82 |
Study arm | ||||||
Standard of care | 1 | 1 | ||||
Intervention | 4.03 | 1.49–10.9 | 0.006 | 4.28 | 1.5–11.85 | 0.005 |
Study site | ||||||
IDC Mulago | 1 | 1 | ||||
Kasangati H C IV | 2.79 | 1.09–7.12 | 0.031 | 4.13 | 1.44–11.86 | 0.008 |
Currently have spouse/partner | ||||||
Yes | 1 | 1 | ||||
No | 0.64 | 0.27–1.53 | 0.32 | 0.85 | 0.33–2.18 | 0.74 |
Highest level of education | ||||||
None | 1 | 1 | ||||
Primary | 1.12 | 0.13–9.40 | 0.91 | 1.043 | 0.12–9.8 | 0.97 |
Secondary | 1.17 | 0.14–9.63 | 0.88 | 1.26 | 0.14–11.13 | 0.83 |
Tertiary | 0.76 | 0.08–6.88 | 0.80 | 1.14 | 0.11–11.4 | 0.911 |
Currently employed | ||||||
Yes | 1 | 1 | ||||
No | 0.92 | 0.38–2.17 | 0.84 | 0.92 | 0.35–2.4 | 0.860 |
Antiretroviral therapy duration | 1.016 | 0.89–1.16 | 0.800 | 1.017 | 0.94–1.094 | 0.658 |